Phoenix Rising tells QMUL: release the PACE trial data
Mark Berry, Acting CEO of Phoenix Rising, presents the Board of Directors’ open letter to Queen Mary University of London (QMUL) urging them to release the PACE trial data, and hopes that other non-UK organisations will join British charities in the same request...
Discuss the article on the Forums.

Abstract from 12th International Conference On Malignancies In AIDS And Other Acquire

Discussion in 'XMRV Research and Replication Studies' started by taniaaust1, Aug 14, 2010.

  1. taniaaust1

    taniaaust1

    Messages:
    11,870
    Likes:
    12,565
    Sth Australia
    I just came across the following and dont think anyone has posted about this at the forum yet??

    from http://www.mecfs.org.au/news/newsId/23
    http://oham.cancer.gov/objects/pdf/2010ICMAOI_Program_Book.pdf
     
  2. taniaaust1

    taniaaust1

    Messages:
    11,870
    Likes:
    12,565
    Sth Australia
    Three parts of the above really stood out to me
     
  3. Stone

    Stone Senior Member

    Messages:
    371
    Likes:
    12
    NC
    "Some DNA-PCR negative patient blood samples represent false negatives and molecular analysis using DNA from unstimulated blood cells is not yet sufficient for XMRV identification."

    Music to my ears. We need more scientists getting this word out besides WPI and maybe a handful of others at the most.

    What an exciting study, very promising indeed! I can't wait to read the whole text. This is the kind of thing we really need and it looks like this is going to be oh so helpful to us, I'm sure. Great find! You've got a good eye.

    Thanks a million for posting it. I'm looking forward to the comments of others on this abstract. Any idea where, when, and if the full study will be published?
     
  4. cfssufferer

    cfssufferer

    Messages:
    26
    Likes:
    0
    Adelaide, Australia

See more popular forum discussions.

Share This Page